My bookmarksSign up free

Commission Implementing Decision (EU) 2018/1305 of 26 September 2018 on the terms and conditions of the authorisation of a biocidal product family containing deltamethrin referred by Sweden in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document number C(2018) 5503) (Text with EEA relevance.)

Commission Implementing Decision (EU) 2018/1305 of 26 September 2018 on the terms and conditions of the authorisation of a biocidal product family containing deltamethrin referred by Sweden in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document number C(2018) 5503) (Text with EEA relevance.)

Implementing Decision (EU) 2018/1305 Β· Decision Β· 3 articles

Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β†—

Article 1

This Decision applies to the biocidal product family identified by the asset number SE-0017809-0000 in the Register for Biocidal Products.

Article 2

The minimum and maximum percentage for the concentration of the active substance in the biocidal product family referred to in Article 1, as referred to in Article 22(2)(e) of Regulation (EU) No 528/2012, shall be expressed by considering the active substance as it was approved, which includes the main constituent of the active substance and any additives or impurities. Under the terms and conditions set out in paragraph 1, the biocidal product family referred to in Article 1 meets the conditions laid down in Article 19(1)(c) of Regulation (EU) NoΒ 528/2012.

Article 3

This Decision is addressed to the Member States.

Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next